Image

Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy

Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy

Recruiting
3-18 years
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to evaluate the effectiveness of Magnetoencephalography (MEG) in the preoperative assessment of children with refractory epilepsy, particularly in identifying the seizure focus, and to compare it with the gold standard methods of Stereo-electroencephalography (SEEG) and Electrocorticography (ECoG).

The main questions this study aims to answer are:

  1. How consistent is MEG with SEEG/ECoG in locating the epileptic focus in children with refractory epilepsy?
  2. What is the clinical efficacy of MEG in identifying epileptic foci?

Participants will:

  1. Be divided into 2 groups: the case group and the control group. Participants in the case group will undergo both MEG and SEEG/ECoG for preoperative assessment, while patients in the control group will undergo only SEEG/ECoG before surgery.
  2. Be followed up at 1, 3, 6, and 12 months after surgery to assess seizure control, neurological function, and quality of life.

Eligibility

Inclusion Criteria:

  1. Age range: 3-18 years old;
  2. Clinically diagnosed with refractory epilepsy;
  3. Capable of cooperating with magnetoencephalography evaluation and recording.

Exclusion Criteria:

  1. Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination.
  2. Patients using drugs that affect central nervous system function;
  3. Patients who are not suitable for surgical procedures;
  4. Patients with progressive neurological disorders.

Study details
    Refractory Epilepsy in Children

NCT07064421

Guangzhou Women and Children's Medical Center

20 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.